<DOC>
	<DOCNO>NCT00092105</DOCNO>
	<brief_summary>The purpose study determine protective effect approve medication asthma allergic rhinitis ( inflammation mucous membrane nose ) upon exposure cat .</brief_summary>
	<brief_title>Study MK0476 ( Montelukast Sodium ) Effects Asthma Nasal Symptoms Upon Exposure Cats ( 0476-256 )</brief_title>
	<detailed_description>The duration treatment 2 week .</detailed_description>
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Rhinitis , Allergic</mesh_term>
	<mesh_term>Rhinitis , Allergic , Perennial</mesh_term>
	<mesh_term>Montelukast</mesh_term>
	<criteria>Increased sensitivity cat allergen proven positive allergy testing , decrease lung function increase symptom allergic rhinitis ( runny nose ) upon exposure cat . Medical history lung disorder ( asthma ) recent upper respiratory tract infection .</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Rhinitis , Allergic</keyword>
</DOC>